Prix FOB
Obtenir le dernier prix( Negotiable )
|100 Gram Minimum Order
Pays:
China
N ° de modèle:
IP0004-B
Prix FOB:
( Negotiable ) Obtenir le dernier prix
Localité:
china
Prix de commande minimale:
-
Commande minimale:
100 Gram
Packaging Detail:
Aluminum foil bag, PTFE Bottle, or meet your requirment
Heure de livraison:
Within one week
Capacité de Fournir:
10 Kilogram per Month
Payment Type:
D/P, L/C, T/T
Groupe de produits :
Personne àcontacter Mr. James
Building A, NO.688,Qiushi Road,Jinshan District, Shanghai, shanghai
Axitinib is an investigational drug being developed by Pfizer for treating advanced renal cell carcinoma (ARCC) and hepatocellular carcinoma.The drug is being investigated as a single dose therapy, as well as in combination with chemotherapy.Pfizer submitted a new drug application for the treatment of advanced renal cell carcinoma based on the Phase III AXIS ***2 trial.The drug has been approved for review by the FDA in June ***1.The drug was also accepted for review by the European Medicines Agency in June ***1.The review will be based on the Phase III AXIS ***2 trial.More than **0,**0 people are diagnosed with renal cell carcinoma every year and **2,**0 people die as a result of the cancer.
| Pays: | China |
| N ° de modèle: | IP0004-B |
| Prix FOB: | ( Negotiable ) Obtenir le dernier prix |
| Localité: | china |
| Prix de commande minimale: | - |
| Commande minimale: | 100 Gram |
| Packaging Detail: | Aluminum foil bag, PTFE Bottle, or meet your requirment |
| Heure de livraison: | Within one week |
| Capacité de Fournir: | 10 Kilogram per Month |
| Payment Type: | D/P, L/C, T/T |
| Groupe de produits : | Pharma intermediate |
